



Biomedical research often focuses on the detection of re-
lationships (associations) between variables (phenomena 
or attributes). It is important to note that association may 
or may not indicate a causal relationship. This depends on 
many factors and is beyond the scope of this text. The fo-
cus is on the odds ratio, which is one of the measures that 
can be used to quantify the association between two bi-
nary or dichotomous variables, ie, those that can take only 
two values, eg, alive/dead or ill/healthy.
EXAMPLES
Let us assume that two variables of interest are “exposure 
of women to pharmacological estrogens” (yes/no) and “di-
agnosis of endometrial cancer” (yes/no). We may ask the 
question: “Is the exposure (to estrogens) associated with 
cancer diagnosis?” For this purpose, let us imagine two 
studies.
First study: At a gynecology ward, we examined 74 pa-
tients with endometrial cancer and 664 patients without 
cancer. We found that 56 out 74 women with cancer had 
previously been exposed to estrogens. The prevalence of 
estrogen exposure was therefore 56/74 or 0.757 or 75.7%. 
At the same time, among the 664 women without cancer, 
274 had been exposed to estrogens, giving a prevalence of 
274/664 or 0.413 or 41.3%.
Second study: 330 women are exposed to pharmacolog-
ical estrogens and over the next 5 years, 56 of them are 
diagnosed with endometrial cancer. The cancer incidence 
is 56/330 or 0.170 or 17.0%. At the same time, 408 similar 
women are not exposed to estrogen and 18 of them are 
diagnosed with endometrial cancer – the incidence in this 
group is 18/408 or 0.044 or 4.4%.
In both studies, the results can be summarized as shown 
in Table 1.
The number of subjects in each category is the same for 
both studies. However, due to different study designs, con-
clusions that can be derived from each study are also dif-
ferent.
In the first study, we look at the “existing situation,” or the 
so-called cross-sectional convenience sample of subjects 
at a gynecology ward. Obviously, we cannot assess the risk 
of cancer based on such a study. The risk (or probability) 
quantifies the share of “events” in the total number of “at-
tempts,” eg, the risk of scoring a point (“event”) in a series 
of 10 throws of the ball (“attempts”) in basketball. The risk 
is, therefore, based on incidence (ie, it is determined pro-
spectively), whereas in the first study we can calculate only 
prevalence. Using the data from the first study, one can cal-
culate the prevalence ratio and prevalence difference, as 
well as odds ratio. All three indicators provide a “numerical 
value” of an association between estrogen exposure and 
cancer diagnosis.
Prevalence difference and prevalence ratio
In women with cancer, the prevalence of estrogen ex-
posure was 75.7% (see above). In women without 
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TAbLE 1. The results of a hypothetical study assessing the as-




yes (a) 56 (b) 18 (a + b) 74
no (c) 274 (d) 390 (c + d) 664
Total (a + c) 330 (b + d) 408 738
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cancer, the prevalence was 41.3%. If one is to “look at the 
table” from a “different angle,” then the prevalence of can-
cer among women exposed to estrogen is 56/330 or 17% 
and among nonexposed women it is 18/408 or 4.4%.
Prevalence difference is therefore 75.7-41.3 = 34.4%, or al-
ternatively, 17.0-4.4 = 12.6%
Prevalence ratio is 75.7/41.3 = 1.83, or alternatively, 
17.0/4.4 = 3.85
Interpretation: The proportion of women with a history of 
estrogen exposure among women with cancer is abso-
lutely 34.4% higher and relatively 83% higher than among 
women without cancer. Alternatively, the proportion of 
women with cancer among women exposed to estrogens 
is absolutely 12.6% and relatively 3.85 times higher than 
among women not exposed to estrogens.
Conclusion: Having endometrial cancer is related to previ-
ous exposure to estrogens.
Note: Prevalence difference or ratio differs depending on 
the way we “look at the table,” but in both cases both in-
dices suggest an association between estrogen exposure 
and cancer.
Odds ratio
Let us first define the term and explain how it differs from 
probability (risk). As mentioned, probability is a proportion 
of events in a number of attempts. For example, the proba-
bility of getting “six” in one throw of a fair dice is 1/6 = 16.7%. 
Probability can have values between 0 and 1 (ie, 0% and 
100%). The probability of an unavoidable event (the sun 
rising tomorrow morning) is 100%. The probability of an 
impossible event (getting seven in a single throw of dice) is 
0%. The odds of an event are the probability that the event 
will occur divided by the probability that it will not occur. 
Therefore, odds = (probability of event) / (1 – probability 
of event). For example, the odds of getting six in one roll 
of dice are 1/6 (probability of getting six) divided by 5/6 
(probability of not getting six). Therefore, the odds of get-
ting a six are [1/6]/[5/6] = 1/5 = 0.20. The odds of an event 
can range from 0 to infinity. Odds lower than 1 mean that 
it is more likely that the event will not occur than that it will 
occur. Odds above 1 mean that it is more likely that the 
event will occur. Odds ratio quantifies the relationship be-
tween two binary variables based on a comparison of the 
odds of the event under two different conditions. In the 
case discussed here, the event is cancer diagnosis, and two 
conditions are the presence or absence of estrogen expo-
sure. The odds ratio of interest is the ratio of the odds of 
estrogen exposure in women with cancer and the odds of 
estrogen exposure in women without cancer. Therefore:
Odds of estrogen exposure in women with cancer: 
56/18 = 3.11.
Odds of estrogen exposure in women without cancer: 
274/390 = 0.70.
Odds ratio is therefore: 3.11/0.70 = 4.42.
Interpretation: The odds of finding previous estrogen ex-
posure are 4.42 times higher among women with endo-
metrial cancer than among women without cancer.
Conclusion: The presence of endometrial cancer is associ-
ated with a previous exposure to pharmacological estro-
gens.
Note: If one is to “look at the data” another way around, 
ie, at the odds of finding cancer in exposed women and 
the odds of finding cancer in non-exposed women, there 
would be the following situation:
Odds of cancer in exposed women: 56/274 = 0.204
Odds of cancer in non-exposed women: 18/390 = 0.046
Odds ratio: 0.204/0.046 = 4.42
Hence, odds ratio gives an identical numerical “value” of an 
association, irrespective of the way of “looking” at the data.
However, there are two questions still remaining. First, the 
one from the title of this paper – what are the odds that a 
person in the possession of this issue of the Croatian Medi-
cal Journal will read this article? And second, what about 
the study following women taking estrogen for 5 years? 
Read more about these topics in our next column!
